Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Vaccinex Inc. (VCNX)

1.735   -0.045 (-2.53%) 10-01 15:16
Open: 1.72 Pre. Close: 1.78
High: 1.76 Low: 1.71
Volume: 446,777 Market Cap: 35M
Vaccinex, Inc. is a clinical-stage biotechnology company, which engages in the development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is headquartered in Rochester, New York and currently employs 44 full-time employees. The firm is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The company provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. The company also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.823 - 1.832 1.832 - 1.84
Low: 1.729 - 1.739 1.739 - 1.748
Close: 1.763 - 1.78 1.78 - 1.795

Technical analysis

as of: 2020-10-01 2:40:57 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.50     One year: 7.72
Support: Support1: 1.63    Support2: 1.36
Resistance: Resistance1: 4.71    Resistance2: 6.61
Pivot: 3.52
Moving Average: MA(5): 1.76     MA(20): 3.89
MA(100): 4.62     MA(250): 4.88
MACD: MACD(12,26): -1.02     Signal(9): -0.74
Stochastic oscillator: %K(14,3): 2.61     %D(3): 2.26
RSI: RSI(14): 24.84
52-week: High: 12.23  Low: 1.63  Change(%): -74.0
Average Vol(K): 3-Month: 112822  10-Days: 256197

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
VCNX has closed above bottom band by 25.2%. Bollinger Bands are 258.2% wider than normal. The large width of the bands suggest high volatility as compared to VCNX's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Tue, 29 Sep 2020
A Little Luck Can Go a Long Way with Vaccinex Inc. (VCNX) as it 5-day change was -68.01% - News Daemon

Tue, 29 Sep 2020
Shares in Vaccinex, Inc. (VCNX) -63.92 % down, YTD - Marketing Sentinel

Mon, 28 Sep 2020
Should Vaccinex Inc (VCNX) be in Your Portfolio? - InvestorsObserver

Mon, 28 Sep 2020
We Analyzed the Future Direction of Vaccinex Inc. (VCNX), Here is What We Found - The News Heater

Fri, 25 Sep 2020
Does Vaccinex Inc (VCNX) Have What it Takes to be in Your Portfolio? - InvestorsObserver

Wed, 23 Sep 2020
What is the Market's View on Vaccinex Inc (VCNX) Stock's Price and Volume Trends - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 20
Shares Float (M) 8
% Held by Insiders 23.39
% Held by Institutions 59.38
Shares Short (K) 52
Shares Short P. Month (K) 41

Stock Financials

EPS -1.803
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -1.740
Profit Margin
Operating Margin -6850.50
Return on Assets (ttm) -338.5
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) 0.016
Sales Per Share 0.020
EBITDA (p.s.) -1.363
Qtrly Earnings Growth
Operating Cash Flow (M) -29
Levered Free Cash Flow (M) -19

Stock Valuations

PE Ratio -0.96
PEG Ratio
Price to Book value -0.99
Price to Sales 86.03
Price to Cash Flow -1.19

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.